Acute kidney injury caused by administration of zaltoprofen in a cat |
Baek, Woon-Bum
(College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University)
Kim, Hak-Hyun (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) Kang, Byeong-Teck (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) Kang, Ji-Houn (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) Yang, Mhan-Pyo (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) |
1 | Beale BS. Use of nutraceuticals and chondroprotectants in osteoarthritic dogs and cats. Vet Clin North Am Small Anim Pract 2004, 34, 271-289. DOI |
2 | Court MH, Greenblatt DJ. Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms. Pharmacogenetics 2000, 10, 355-369. DOI |
3 | Gaunt SD, Baker DC, Green RA. Clinicopathologic evaluation N-acetylcysteine therapy in acetaminophen toxicosis in the cat. Am J Vet Res 1981, 42, 1982-1984. |
4 | Hietanen E, Vainio H. Interspecies variations in small intestinal and hepatic drug hydroxylation and glucuronidation. Acta Pharmacol Toxicol (Copenh) 1973, 33, 57-64. |
5 | Innes JF, Clayton J, Lascelles BDX. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec 2010, 166, 226-230. DOI |
6 | Ito A, Mori Y. Effect of a novel anti-inflammatory drug, 2-(10,11-dihydro-10-oxo-dibenzo[b,f]-thiepin-2-yl)propionic acid (CN-100), on the proteoglycan biosynthesis in articular chondrocytes and prostaglandin E2 production in synovial fibroblasts. Res Commun Chem Pathol Pharmacol 1990, 70, 131-142. |
7 | King JN, Hotz R, Reagan EL, Roth DR, Seewald W, Lees P. Safety of oral robenacoxib in the cat. J Vet Pharmacol Ther 2012, 35, 290-300. DOI |
8 | Lascelles BD, Court MH, Hardie EM, Robertson SA. Nonsteroidal anti-inflammatory drugs in cats: a review. Vet Anaesth Analg 2007, 34, 228-250. DOI |
9 | Luna SP, Basilio AC, Steagall PVM, Machado LP, Moutinho FQ, Takahira RK, Brandao CVS. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am J Vet Res 2007, 68, 258-264. DOI |
10 | Pezzilli R, Morselli-Labate AM, Corinaldesi R. NSAIDs and acute pancreatitis: a systematic review. Pharmaceuticals (Basel) 2010, 3, 558-571. DOI |
11 | Richardson JA. Management of acetaminophen and ibuprofen toxicoses in dogs and cats. J Vet Emerg Crit Care 2000, 10, 285-291. DOI |
12 | Simpson KW. Pancreatitis and triaditis in cats: causes and treatment. J Small Anim Pract 2015, 56, 40-49 DOI |
13 | Sparkes AH, Heiene R, Lascelles BD, Malik R, Sampietro LR, Robertson S, Scherk M, Taylor P; ISFM and AAFP. ISFM and AAFP consensus guidelines: long-term use of NSAIDs in cats. J Feline Med Surg 2010, 12, 521-538. DOI |
14 | Tsurumi K, Kyuki K, Niwa M, Mibu H, Fujimura H. Pharmacological investigations of the new antiinflammatory agent 2-(10,11-dihydro-10-oxodibenzo[b,f] thiepin-2-yl)propionic acid. 2nd communication: inhibitory effects on acute inflammation and prostaglandin-related reactions. Arzneimittelforschung 1986, 36, 1801-1805. |
15 | Weir MR. Renal effects of nonselective NSAIDs and coxibs. Cleve Clin J Med 2002, 69 (Suppl), SI53-58. |
![]() |